L-5-methylfolate and Depression

The role of L-5-methylfolate in the treatment of patients with depression has once again been highlighted by an article published in the American Journal of Psychiatry in 2016.

After successfully treating treatment resistant depression in a patient deficient in cerebrospinal fluid (CSF) tetrahydrobiopterin with sapropterin, investigators searched for this and other potential metabolic abnormalities in 33 patients with treatment resistant depression.
Depression and L-5-methylfolate
The study found that a very high proportion of teenagers and young adults with well documented treatment resistant depression had some kind of CSF metabolite abnormality and by far the most common abnormality was normal serum folate and a low L-5-methylfolate level, suggesting a functional deficit in the active form of folate that is involved in the production of the monoamine neurotransmitters that seem to be closely tied to depression.

The researchers then treated these patients in an open label fashion and found some evidence that reversing this apparent deficiency improved depression.


Previous:Which isomers are present in the nutrient? Is L or (6S) best? What about (6S)+(6R) or DL? Next:Prevent Neural Tube Defects? A Cohort Study of 34,000 Pregnant Women: Supplementing 1 Year in Advance Cuts Spontaneous Preterm Birth Risk by 50%
Let's talk

We're Here to Help

Contact Us
 

展开
TOP